YZi Labs: Condemns CEA Industries Board for Adopting Poison Pill Plan and Depriving Shareholder Rights

Odaily News YZi Labs is reviewing the response actions taken by CEA Industries regarding the written consent solicitation process initiated by YZi Labs. These actions include the adoption of a poison pill plan and amendments to the company's bylaws, aimed at thwarting and delaying shareholders from exercising their rights. YZi Labs believes the board's purpose is to entrench itself, and has currently postponed the 2025 annual meeting until after the December 17 anniversary date. Furthermore, YZi Labs refutes CEA Industries' statement about never having considered alternative token strategies, pointing out that the company's CEO, David Namdar, explicitly stated at an industry conference in November 2025 that he was considering a shift towards assets like Solana. YZi Labs urges the board to avoid further manipulative actions and to ensure fairness in the director nomination and election process.